Windtree Therapeutics, Inc.
WINT
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.59% | -139.58% | 153.69% | 37.88% | -82.15% |
| Total Depreciation and Amortization | -29.17% | -19.05% | -32.06% | 39.09% | -89.83% |
| Total Amortization of Deferred Charges | -425.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.08% | 100.90% | -817.27% | -1,172.34% | 189.17% |
| Change in Net Operating Assets | -29.68% | 25.29% | -10.21% | -830.00% | 1,174.63% |
| Cash from Operations | -14.23% | 18.32% | -3.31% | -67.20% | 33.49% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -43,091.67% | -- | -- | 100.00% | -- |
| Total Debt Issued | 338.99% | -- | -- | -- | -- |
| Total Debt Repaid | -- | 28.76% | 52.56% | -97.85% | 100.00% |
| Issuance of Common Stock | -- | 67.52% | 511.13% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 337.20% | 74.18% | 507.29% | 3,078.97% | -85.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.07% | 68.32% | 82.90% | 112.12% | -110.31% |